LGND
LGND
NASDAQ · Pharmaceuticals

Ligand Pharmaceuticals

$295.92
+11.01 (+3.86%)
As of Jun 25, 9:58 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -89.3% upside
Low Target $18.80
Average Target $31.56
High Target $35.41
Current Price $295.92
Current
$295.92
Target
$31.56
$18.80 $31.56 avg $35.41
Scenario Analysis
Bear Case
$18.80
-93.6%
Low target
Base Case
$31.56
-89.3%
Avg target
Bull Case
$35.41
+-88.0%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$276.20
7.1% from high
52-Week Low
$110.00
+169.0% from low
50-Day SMA
$193.47
+53.0% vs SMA
200-Day SMA
$162.08
+82.6% vs SMA
RSI (14)
38.7
Neutral
Target vs 52W High
$31.56
-88.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.0%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.0%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +43.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +215.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +169.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.7%